Zhiqiang Shu
Stock Analyst at Berenberg
(0.12)
# 3,803
Out of 4,670 analysts
8
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $26.79 | -2.95% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $0.90 | +1,228.90% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $94.15 | -4.41% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $2.51 | +1,095.22% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.52 | +2,202.82% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $22.05 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $1.01 | +4,576.62% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $2.81 | +1,714.95% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $26.79
Upside: -2.95%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $0.90
Upside: +1,228.90%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $94.15
Upside: -4.41%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $2.51
Upside: +1,095.22%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.52
Upside: +2,202.82%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $22.05
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $1.01
Upside: +4,576.62%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $2.81
Upside: +1,714.95%